Regulatory risk assistance
Your company is in risk with ANVISA?
Identify critical non-compliance gaps in BPF before being fined, banned or sanctioned.
Urgent diagnosis
Response within 1 business hour
The cost of ignoring nonconformity
Each day without action exponentially increases the risk of your operation.
Interdiction of operation
Immediate suspension of production and blocking of batches.
Fines and sanctions
Regulatory penalties that can reach R$1.5 million.
Loss of certifications
Cancellation of GMP certificate and qualifications.
Problems with suppliers
Breakdown of supply chain and contracts.
Do you recognize your company in any of these scenarios?
Companies with upcoming audit
ANVISA inspection scheduled or imminent.
Open nonconformities
Notes without COVER or late.
Problems with ANVISA
TIs, infraction notices or demands.
Supplier failures
Third-party qualification or audit failed.
Surgical performance in accordance with ANVISA and BPF
Quick compliance analysis
Complete technical survey within 7 days.
Specialized technical audit
Assessment by experts with ANVISA experience.
Corrective action plan (CAPA)
CAPA structured, traceable and auditable.
Preparing for inspections
Real inspection training and simulation.
Who is behind T&B Pharma
- Certified experts in GMP and ANVISA regulations
- More than 15 years of experience in the pharmaceutical industry
- Expertise in critical pre-inspection audits and adjustments
- History of passing national and international inspections
From urgency to action plan in 4 steps
Immediate contact
Priority service via WhatsApp.
Scenario analysis
We understand your current regulatory risk.
Technical diagnosis
We identify critical non-conformities.
Action plan
We carry out the remediation with you.
Don't wait for the next inspection
Avoid regulatory risks. Speak to an expert now.
Every day without action brings your company closer to being fined. Get ahead of the curve with an immediate technical diagnosis.
